Charlotte Grayson-Mathis, MD
Internal Medicine · Fayetteville, GANPI 1497779391
Payments from drug & device makers
Across 475 payments — averaging $20,196 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$7.2M
- Boehringer Ingelheim$1.3M
- Vertex$591K
- Merck$241K
- Genentech, Inc.$101K
- AstraZeneca$74K
- plus $92K from 17 others
Across 6 payments — averaging $302.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 212 | $7,157,035 |
| Boehringer Ingelheim | 39 | $1,337,768 |
| Vertex | 4 | $590,808 |
| Merck | 9 | $241,153 |
| Genentech, Inc. | 18 | $100,663 |
| AstraZeneca | 4 | $73,651 |
| Boehringer Ingelheim International GmbH | 109 | $42,991 |
| Pfizer | 5 | $24,774 |
| Janssen Research & Development, LLC | 4 | $14,756 |
| Novartis | 3 | $7,958 |
| Novo Nordisk AS | 49 | $1,168 |
| Novo Nordisk | 5 | $111 |
| Astellas Pharma US Inc | 1 | $100 |
| Johnson & Johnson | 2 | $40 |
| Abbott | 2 | $39 |
| GSK | 2 | $34 |
| Lilly USA, LLC | 1 | $24 |
| Medtronic | 1 | $22 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Amgen | 1 | $18 |
| AbbVie | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Mannkind Corporation | 1 | $13 |
How this compares
$9,593,174 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Fayetteville
- Frank ColeFayetteville$673K
- Paul BradleySavannah$76.4M
- Kimball JohnsonAtlanta$51.1M
- Bram WieskopfWoodstock$21.9M
- Dwight BlakeUnion City$13.3M
- Christopher RecknorGainesville$9.2M
- James HarperJohns Creek$9.2M
- Robert Springer IiiAtlanta$5.3M
- Thomas MoriaritySavannah$4.6M
- Charles KempAlbany$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.